XML 78 R51.htm IDEA: XBRL DOCUMENT
v3.25.4

Net Loss per Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share, Basic and Diluted | The calculation of earnings per common share is as follows (in thousands, except share data):
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
Numerator: |  |  |  |  |
Net loss | $ | (312,763) |  |  | $ | (547,029) |  |  | $ | (892,869) |
Denominator |  |  |  |  |
Weighted average common shares outstanding | 55,457,676 |  | 51,894,639 |  | 48,610,507
Net loss per share | $ | (5.64) |  |  | $ | (10.54) |  |  | $ | (18.37) |
Summary of Anti-Dilutive Shares | The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to Ginkgo Bioworks Holdings, Inc. common stockholders for the periods presented because including them would have been anti-dilutive:
| As of December 31,
| 2025 |  | 2024 |  | 2023
Unvested PSUs | 4,407,287 |  | — |  |  | — |
Warrants to purchase Class A common stock | 1,295,622 |  | 1,295,622 |  | 1,295,622
Unvested RSUs | 1,262,853 |  | 3,327,398 |  | 3,804,189
Earnout shares (1) | 3,793,063 |  | 3,794,243 |  | 3,803,049
Outstanding stock options | 366,567 |  | 767,520 |  | 192,208
Escrow shares (2) | — |  |  | 20,332 |  |  | — |
| 11,125,392 |  | 9,205,115 |  | 9,095,068
(1)Represents employee and non-employee earnout shares for which the service-based and/or market-based vesting conditions have not been satisfied. (2)Represents restricted common stock issued in connection with asset acquisitions, held in escrow for indemnification purposes, and subject to forfeiture.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration